North America Fat Reduction Market
市场规模(十亿美元)
CAGR : %
Forecast Period |
2024 –2033 |
Market Size (Base Year) |
|
Market Size (Forecast Year) |
USD 11,773.56 |
CAGR |
|
Major Markets Players |
>北美减脂市场,按类型(手术减脂、非侵入性减脂和微创减脂)、应用(腹部脂肪、大腿脂肪、臀部脂肪、上臂脂肪、面部脂肪沉积和膝盖脂肪)、性别(女性和男性)、年龄组(成人、老年人和儿童)、最终用户(医院、多专科诊所、皮肤病中心、医疗水疗中心和美容中心等)、分销渠道(直接招标、零售销售、第三方分销商等)、行业趋势和预测到 2033 年。
北美减脂市场分析与洞察
由于对微创和非侵入性手术的需求不断增长,以及男女在美容方面的差异缩小,北美减脂市场预计将在预测期内增长。市场还受到日益增长的审美意识和美容标准以及日益进步的技术的影响。然而,北美减脂市场预计将受到手术成本高、手术相关风险增加以及产品召回的阻碍。
个性化治疗方案、与其他美容手术的结合、年轻人减肥的信念和趋势、对包容性和多样性的关注以及产品线的扩展预计将成为市场增长的机会。然而,该手术的短期疗效和可持续性较低以及恢复时间较长预计将对市场增长构成挑战。
发达国家和发展中国家对减脂市场的需求都在增加,其背后的原因是其有效性和可用性。因此,许多市场参与者提供具有创新性的减脂产品,为北美减脂市场的增长铺平了道路。
Data Bridge Market Research分析,北美减脂市场预计到2033年将达到117.7356亿美元的价值,预测期内的复合年增长率为9.9%。
报告指标 |
细节 |
预测期 |
2023 至 2033 年 |
基准年 |
2022 |
历史岁月 |
2021 (可定制为 2015-2020) |
定量单位 |
收入(百万美元) |
涵盖的领域 |
类型(手术减脂、非侵入性减脂和微创减脂)、应用(腹部脂肪、大腿脂肪、臀部脂肪、上臂脂肪、面部脂肪沉积和膝盖脂肪)、性别(女性和男性)、年龄组(成人、老年人和儿童)、最终用户(医院、多专科诊所、皮肤病学中心、医疗水疗中心和美容中心等)、分销渠道(直接招标、零售、第三方分销商等) |
覆盖国家 |
美国、加拿大、墨西哥、哥斯达黎加、多米尼加共和国、巴拿马、萨尔瓦多、危地马拉、洪都拉斯和尼加拉瓜 |
涵盖的市场参与者 |
Hironic Co Ltd、AbbVie Inc.、Cynosure、Alma Lasers、Candela Corporation、Merz Pharma、Solta Medical(Bausch & Lomb Incorporated 的子公司)、Cutera、MicroAire Surgical Instruments, LLC.、Mentor Worldwide LLC、Venus Concept、Erchonia Corporation、BTL Group of Companies、Leaderma Inc.、MÖLLER Medical、Fotona 和 Implantech. 等。 |
北美减脂市场定义
减脂是指减少个人体内的脂肪或脂肪组织量。它涉及旨在促进减肥和降低体脂总体百分比的策略和技术。可以通过手术和非手术程序减少体脂。有各种治疗方法,例如激光溶脂、冷冻溶脂、抽脂、注射治疗等。
北美减脂市场动态
本节旨在了解市场驱动因素、优势、机遇、限制和挑战。下面将详细讨论所有这些内容:
驱动程序
- 对微创和非侵入性手术的需求不断增加
与传统的减脂技术(包括激光和其他基于能量的设备)相比,微创和非侵入性手术的使用已经发生了变化。对于手术或非手术程序的使用,已经开发了专门设计的用于微创手术的仪器。
微创手术是在观察镜和专门配备的手术器械的帮助下进行的手术。使用微创手术不会造成任何伤害或造成轻微伤害,恢复时间更短,因此微创手术的需求和使用不断增加。手术兴起的其他原因包括老龄化人口的增加以及对医疗设施的需求,包括对患者友好的技术,这些技术的医疗要求最高,这可以进一步减轻医疗设施的负担。
微创/非侵入性手术符合患者的舒适度。它们几乎没有任何副作用,恢复时间也很短。因此,人们更愿意接受美容手术。因此,对微创和非侵入性手术的需求增加预计将成为市场驱动力。
克制
- 手术费用高昂
基于现代技术的减脂设备通过使用技术先进的方式(例如基于超声波、激光辅助或射频辅助的减脂设备)减少脂肪,帮助调理和收紧身体各个部位。减脂的费用在不同地点或地区之间存在很大差异。决定减脂费用的关键因素包括确定进行手术的医疗机构或诊所、治疗区域、患处、患者住院时间以及手术的复杂程度等。手术费用高昂是由于手术检查点各异以及使用高科技方式进行此类手术。由于技术先进的减脂设备成本高昂,手术费用也相应上升,因此高昂的手术费用预计会阻碍市场需求。
机会
- 定制治疗方案并与其他美容手术相结合
通过定制治疗方案以及将减脂手术与其他美容治疗相结合,北美减脂市场的公司可以提供量身定制的解决方案,并提升客户的整体治疗体验。这些策略不仅可以优化治疗效果,还表明了满足个人需求和偏好的承诺,从而提高客户满意度和忠诚度。因此,定制治疗方案和与其他美容治疗相结合有望为市场增长创造机会。
挑战
- 长期功效和可持续性
治疗结果可能受到新陈代谢、遗传和生活方式等因素的影响。虽然有些人可能会获得更显著和更持久的益处,但其他人可能需要更多疗程或额外治疗才能获得他们想要的结果。在处理持续性脂肪沉积时,保持长期有效性也是一个问题。减少身体脂肪的治疗对某些身体部位(如下腹部或腰部赘肉)可能效果较差。
长期有效性和可持续性是北美减脂市场面临的重大挑战,预计也将对市场的增长构成挑战。
最新动态
- 2023 年 10 月,MOLLER Medical 将于 2023 年 6 月 1 日至 6 月 3 日举办一场名为 SOFCEP Congress 2023 的活动。本次活动的主题是美容医学以及美容医学手势和干预之间的互补性。这将有助于公司获得更大的客户群。
- 2023 年 8 月,Implantech 将在美国圣地亚哥万豪侯爵酒店举办第二届多专业美学会议,此次会议将有助于该公司展示其在植入物领域的创新。
- 2023年5月,Hironic株式会社宣布,在27日于首尔中区韩国新闻中心举行的Money Today“2023年度消费者满意度大奖”中,荣获美容医疗器械类别的大奖。这有助于该组织在其他公司中树立品牌形象。
- 2023 年 1 月,Fotona 宣布在 IMCAS 大会上展示了其美学产品组合。该公司表示,其美学产品组合 SP Dynamis Nx Line 激光系统内置 CoolMist 皮肤冷却和可选的动态真空技术,以及其他 Fotona 产品和应用程序(如 AvalancheLase、TimeWalker Fotona4D)均已展出,这将有助于该公司接触到更高的客户群。
- 2019 年 6 月,Cutera 针对肌肉塑形市场推出了新产品 truSculpt Flex。该公司推出的这款新产品增加了其在医疗美容领域的产品组合,从而增加了市场对其产品的需求。
北美减脂市场范围
北美减脂市场分为六个显著的细分市场,例如类型、应用、性别、年龄组、最终用户和分销渠道。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略,并确定您的核心应用领域和目标市场的差异。
类型
- 手术减脂
- 非侵入性减脂
- 微创
根据类型,北美减脂市场分为手术减脂、非侵入性减脂和微创减脂。
应用
- 腹部脂肪
- 大腿脂肪
- 臀部脂肪
- 上臂脂肪
- 面部脂肪堆积
- 膝盖脂肪
根据应用,北美减脂市场分为腹部脂肪、大腿脂肪、臀部脂肪、上臂脂肪、面部脂肪堆积和膝盖脂肪。
性别
- 女性
- 男性
根据性别,北美减脂市场分为男性和女性。
年龄组
- 成人
- 老年
- 孩子
根据年龄组,北美减肥市场分为成人、老年人和儿童。
最终用户
- 医院
- 多专科诊所
- 皮肤科中心
- 医疗水疗中心和美容中心
- 其他的
根据最终用户,北美减脂市场分为医院、多专科诊所、皮肤病中心、医疗水疗中心和美容中心。
分销渠道
- 直接招标
- 零售销售
- 第三方分销商
- 其他的
根据分销渠道,北美减脂市场分为直接招标和零售、第三方分销商和其他。
北美减脂市场区域分析/见解
北美减脂市场分为六个显著的部分,如类型、应用、性别、年龄组、最终用户和分销渠道。
本市场报告涉及的国家包括美国、加拿大、墨西哥、哥斯达黎加、多米尼加共和国、巴拿马、萨尔瓦多、危地马拉、洪都拉斯和尼加拉瓜。
由于美国是最大的消费市场,GDP 较高,拥有关键市场参与者,因此预计美国将主导北美减脂市场。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化,这些因素和变化会影响市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外,在对国家数据进行预测分析时,还考虑了北美品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀少竞争而面临的挑战,以及销售渠道的影响。
竞争格局和北美减脂市场份额分析
北美减脂市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品批准、产品宽度和广度、应用优势和产品类型生命线曲线。以上提供的数据点仅与公司对北美减脂市场的关注有关。
北美减脂市场的一些主要参与者包括 Hironic Co Ltd、AbbVie Inc.、Cynosure、Alma Lasers、Candela Corporation、Merz Pharma、Solta Medical(Bausch & Lomb Incorporated 的子公司)、Cutera、MicroAire Surgical Instruments, LLC.、Mentor Worldwide LLC、Venus Concept、Erchonia Corporation、BTL Group of Companies、Leaderma Inc.、MÖLLER Medical、Fotona 和 Implantech 等。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE NORTH AMERICA FAT REDUCTION MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 TYPE LIFELINE CURVE
2.8 DBMR MARKET POSITION GRID
2.9 VENDOR SHARE ANALYSIS
2.1 MARKET APPLICATION COVERAGE GRID
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHT
4.1 PESTEL ANALYSIS
4.2 PORTER’S FIVE FORCES
4.3 BRAND ANALYSIS
4.3.1 KYBELLA
5 INDUSTRY INSIGHTS:
6 NORTH AMERICA FAT REDUCTION MARKET, REGULATIONS
6.1 U.S.
6.1.1 REGULATORY APPROVAL PROCESS, PATHWAYS, AND TIMELINE:
6.1.2 POST-MARKETING SURVEILLANCE:
6.1.3 GOOD MANUFACTURING PRACTICES (GMPS) GUIDELINES:
6.2 CANADA
6.2.1 REGULATORY APPROVAL PROCESS, PATHWAYS, AND TIMELINE
6.2.2 LICENSING AND REGISTRATION
6.2.3 POST EXPIRY OF PATENT REGIME
6.2.4 POST-MARKETING SURVEILLANCE
6.3 MEXICO
6.3.1 REGULATORY APPROVAL PROCESS, PATHWAYS, AND TIMELINE
6.3.2 REGULATORY APPROVAL AGENCIES
6.3.3 LICENSING AND REGISTRATION
6.3.4 POST-MARKETING SURVEILLANCE
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASING DEMAND FOR MINIMALLY INVASIVE AND NON-INVASIVE PROCEDURES
7.1.2 GROWING AESTHETIC CONSCIOUSNESS AND BEAUTY STANDARDS
7.1.3 GROWING TECHNOLOGICAL ADVANCEMENTS
7.1.4 DECREASED DISPARITY BETWEEN MEN AND WOMEN FOR AESTHETIC PROCEDURES
7.2 RESTRAINTS
7.2.1 HIGH COST OF PROCEDURES
7.2.2 INCREASED RISKS ASSOCIATED WITH THE PROCEDURES
7.2.3 PRODUCT RECALL
7.3 OPPORTUNITIES
7.3.1 CUSTOMIZED TREATMENT PLANS AND INTEGRATION WITH OTHER AESTHETIC PROCEDURES
7.3.2 BELIEF AND TREND OF FAT REDUCTION IN YOUNG ADULTS
7.3.3 FOCUS ON INCLUSIVITY AND DIVERSITY AND EXPANSION OF PRODUCT LINES
7.4 CHALLENGES
7.4.1 LONG-TERM EFFICACY AND SUSTAINABILITY
7.4.2 LONGER RECOVERY TIME OF THE PROCEDURE
8 NORTH AMERICA FAT REDUCTION MARKET, BY TYPE
8.1 OVERVIEW
8.2 SURGICAL FAT REDUCTION
8.2.1 LIPOSUCTION
8.2.1.1 BY TYPE
8.2.1.1.1 ULTRASOUND-ASSISTED LIPOSUCTION
8.2.1.1.2 LASER-ASSISTED LIPOSUCTION
8.2.1.1.3 TUMESCENT LIPOSUCTION
8.2.1.1.4 SUPER-WET TECHNIQUE
8.2.1.2 BY APPLICATION
8.2.1.2.1 ABDOMINAL FAT
8.2.1.2.2 THIGHS FAT
8.2.1.2.3 BUTTOCK FAT
8.2.1.2.4 UPPER-ARM FAT
8.2.1.2.5 FACIAL FAT-DEPOSITS
8.2.1.2.5.1 SUBMENTAL AREAS
8.2.1.2.5.2 MALAR
8.2.1.2.5.3 MANDIBULAR
8.2.1.2.6 KNEE FAT
8.2.2 SURGICAL REJUVENATION
8.2.2.1 FACE LIFT
8.2.2.2 NECK LIFT
8.2.3 CHIN IMPLANT
8.2.3.1 SILICONE CHIN IMPLANTS
8.2.3.2 OTHERS
8.2.4 PORUS IMPLANTS
8.2.4.1 TEFLON
8.2.4.2 GORE-TEX
8.2.4.3 MEDPORE IMPLANTS
8.3 NON-INVASIVE FAT REDUCTION
8.3.1 CRYOLIPOLYSIS
8.3.1.1 COOL SCULPTING
8.3.1.2 COOL SCULPTING ELITE
8.3.1.3 COOL TONE
8.3.1.4 OTHERS
8.3.1.4.1 ABDOMINAL FAT
8.3.1.4.2 THIGHS FAT
8.3.1.4.3 BUTTOCK FAT
8.3.1.4.4 UPPER-ARM FAT
8.3.1.4.5 FACIAL FAT-DEPOSITS
8.3.1.4.6 KNEE FAT
8.3.2 ULTRASOUND
8.3.2.1 INTERNAL ULTRASONIC LIPOSUCTION
8.3.2.2 EXTERNAL ULTRASONIC LIPOSUCTION
8.3.2.2.1 ABDOMINAL FAT
8.3.2.2.2 THIGHS FAT
8.3.2.2.3 BUTTOCK FAT
8.3.2.2.4 UPPER-ARM FAT
8.3.2.2.5 FACIAL FAT-DEPOSITS
8.3.2.2.6 KNEE FAT
8.3.3 RADIOFREQUENCY
8.3.3.1 ABDOMINAL FAT
8.3.3.2 THIGHS FAT
8.3.3.3 BUTTOCK FAT
8.3.3.4 UPPER-ARM FAT
8.3.3.5 FACIAL FAT-DEPOSITS
8.3.3.6 KNEE FAT
8.3.4 LOW LEVEL LASER THERAPY
8.3.4.1 ABDOMINAL FAT
8.3.4.2 THIGHS FAT
8.3.4.3 BUTTOCK FAT
8.3.4.4 UPPER-ARM FAT
8.3.4.5 FACIAL FAT-DEPOSITS
8.3.4.6 KNEE FAT
8.3.5 OTHERS
8.4 MINIMALLY INVASIVE
8.4.1 INJECTION LIPOLYSIS
8.4.1.1 DEOXYCHOLIC ACID INJECTIONS
8.4.1.1.1 KYBELLA/BELKYRA
8.4.1.1.1.1 FACIAL FAT-DEPOSITS
8.4.1.1.1.2 UPPER-ARM FAT
8.4.1.1.1.3 ABDOMINAL FAT
8.4.1.1.1.4 THIGHS FAT
8.4.1.1.1.5 KNEE FAT
8.4.1.1.1.6 BUTTOCK FAT
8.4.1.2 PHOSPHATIDYLCHOLINE
8.4.1.2.1 FACIAL FAT-DEPOSITS
8.4.1.2.2 UPPER-ARM FAT
8.4.1.2.3 ABDOMINAL FAT
8.4.1.2.4 THIGHS FAT
8.4.1.2.5 KNEE FAT
8.4.1.2.6 BUTTOCK FAT
8.4.2 OTHERS
9 NORTH AMERICA FAT REDUCTION MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 ABDOMINAL FAT
9.3 THIGHS FAT
9.4 BUTTOCK FAT
9.5 UPPER-ARM FAT
9.6 FACIAL FAT-DEPOSITS
9.6.1 SUBMENTAL AREAS
9.6.2 MANDIBULAR
9.6.3 MALAR
9.7 KNEE FAT
10 NORTH AMERICA FAT REDUCTION MARKET, BY GENDER
10.1 OVERVIEW
10.2 FEMALE
10.3 MALE
11 NORTH AMERICA FAT REDUCTION MARKET, BY AGE GROUP
11.1 OVERVIEW
11.2 ADULT
11.3 GERIATRIC
11.4 CHILD
12 NORTH AMERICA FAT REDUCTION MARKET, BY END USER
12.1 OVERVIEW
12.2 HOSPITALS
12.2.1 BY TYPE
12.2.1.1 PRIVATE
12.2.1.2 PUBLIC
12.2.2 BY CATEGORY
12.2.2.1 TIER 1
12.2.2.2 TIER 2
12.2.2.3 TIER 3
12.3 MULTISPECIALTY CLINICS
12.4 DERMATOLOGY CENTERS
12.5 MEDICAL SPAS AND BEAUTY CENTERS
12.6 OTHERS
13 NORTH AMERICA FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 DIRECT TENDERS
13.3 RETAIL SALES
13.4 THIRD PARTY DISTRIBUTORS
13.5 OTHERS
14 NORTH AMERICA FAT REDUCTION MARKET, BY COUNTRY
14.1 NORTH AMERICA
14.1.1 U.S.
14.1.2 CANADA
14.1.3 MEXICO
14.1.4 COSTA RICA
14.1.5 DOMINICAN REPUBLIC
14.1.6 PANAMA
14.1.7 EL SALVADOR
14.1.8 GUATEMALA
14.1.9 HONDURAS
14.1.10 NICARAGUA
15 COMPANY SHARE ANALYSIS: NORTH AMERICA
16 SWOT ANALYSIS
17 NORTH AMERICA FAT REDUCTION MARKET, COMPANY PROFILINGS
17.1 ABBVIE INC.
17.1.1 COMPANY SNAPSHOT
17.1.2 REVENUE ANALYSIS
17.1.3 PRODUCT PORTFOLIO
17.1.4 RECENT DEVELOPMENTS
17.2 CYNOSURE
17.2.1 COMPANY SNAPSHOT
17.2.2 PRODUCT PORTFOLIO
17.2.3 RECENT DEVELOPMENTS
17.3 ALMA LASERS
17.3.1 COMPANY SNAPSHOT
17.3.2 PRODUCT PORTFOLIO
17.3.3 RECENT DEVELOPMENT
17.4 CANDELA CORPORATION
17.4.1 COMPANY SNAPSHOT
17.4.2 PRODUCT PORTFOLIO
17.4.3 RECENT DEVELOPMENT
17.5 MERZ NORTH AMERICA, INC.
17.5.1 COMPANY SNAPSHOT
17.5.2 PRODUCT PORTFOLIO
17.5.3 RECENT DEVELOPMENTS
17.6 BLACK & BLACK SURGICAL
17.6.1 COMPANY SNAPSHOT
17.6.2 PRODUCT PORTFOLIO
17.6.3 RECENT DEVELOPMENT
17.7 BTL GROUP OF COMPANIES
17.7.1 COMPANY SNAPSHOT
17.7.2 PRODUCT PORTFOLIO
17.7.3 RECENT DEVELOPMENTS
17.8 BAUSCH HEALTH COMPANIES INC.
17.8.1 COMPANY SNAPSHOT
17.8.2 REVENUE ANALYSIS
17.8.3 PRODUCT PORTFOLIO
17.8.4 RECENT DEVELOPMENT
17.9 CUTERA
17.9.1 COMPANY SNAPSHOT
17.9.2 REVENUE ANALYSIS
17.9.3 PRODUCT PORTFOLIO
17.9.4 RECENT DEVELOPMENT
17.1 ERCHONIA CORPORATION
17.10.1 COMPANY SNAPSHOT
17.10.2 PRODUCT PORTFOLIO
17.10.3 RECENT DEVELOPMENT
17.11 FOTONA
17.11.1 COMPANY SNAPSHOT
17.11.2 PRODUCT PORTFOLIO
17.11.3 RECENT DEVELOPMENT
17.12 GENESIS BIOSYSTEMS, INC.
17.12.1 COMPANY SNAPSHOT
17.12.2 PRODUCT PORTFOLIO
17.12.3 RECENT DEVELOPMENT
17.13 HIRONIC CO., LTD.
17.13.1 COMPANY SNAPSHOT
17.13.2 REVENUE ANALYSIS
17.13.3 PRODUCT PORTFOLIO
17.13.4 RECENT DEVELOPMENT
17.14 IMPLANTECH
17.14.1 COMPANY SNAPSHOT
17.14.2 PRODUCT PORTFOLIO
17.14.3 RECENT DEVELOPMENTS
17.15 LEADERMA INC.
17.15.1 COMPANY SNAPSHOT
17.15.2 PRODUCT PORTFOLIO
17.15.3 RECENT DEVELOPMENT
17.16 LYNTON LASERS LTD
17.16.1 COMPANY SNAPSHOT
17.16.2 PRODUCT PORTFOLIO
17.16.3 RECENT DEVELOPMENT
17.17 MENTOR WORLDWIDE LLC (A PART OF JOHNSON & JOHNSON SERVICES, INC.)
17.17.1 COMPANY SNAPSHOT
17.17.2 REVENUE ANALYSIS
17.17.3 PRODUCT PORTFOLIO
17.17.4 RECENT DEVELOPMENT
17.18 MICROAIRE SURGICAL INSTRUMENTS, LLC.
17.18.1 COMPANY SNAPSHOT
17.18.2 PRODUCT PORTFOLIO
17.18.3 RECENT DEVELOPMENT
17.19 MOLLER MEDICAL
17.19.1 COMPANY SNAPSHOT
17.19.2 PRODUCT PORTFOLIO
17.19.3 RECENT DEVELOPMENT
17.2 POLLOGEN (A SUBSIDIARY OF LUMENIS BE LTD.)
17.20.1 COMPANY SNAPSHOT
17.20.2 PRODUCT PORTFOLIO
17.20.3 RECENT DEVELOPMENT
17.21 SILIMED
17.21.1 COMPANY SNAPSHOT
17.21.2 PRODUCT PORTFOLIO
17.21.3 RECENT DEVELOPMENTS
17.22 SURGIFORM INNOVATIVE SURGICAL PRODUCTS
17.22.1 COMPANY SNAPSHOT
17.22.2 PRODUCT PORTFOLIO
17.22.3 RECENT DEVELOPMENT
17.23 VENUS CONCEPT
17.23.1 COMPANY SNAPSHOT
17.23.2 REVENUE ANALYSIS
17.23.3 PRODUCT PORTFOLIO
17.23.4 RECENT DEVELOPMENT
18 QUESTIONNAIRE
19 RELATED REPORTS
表格列表
TABLE 1 AVERAGE COST OF LIPOSUCTION ACROSS THE U.S.
TABLE 2 AVERAGE COSTS OF CHIN AUGMENTATION ACROSS THE U.S.
TABLE 3 NORTH AMERICA FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 4 NORTH AMERICA SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 5 NORTH AMERICA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 6 NORTH AMERICA LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 7 NORTH AMERICA FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 8 NORTH AMERICA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 9 NORTH AMERICA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)
TABLE 10 NORTH AMERICA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 11 NORTH AMERICA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 12 NORTH AMERICA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 13 NORTH AMERICA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 14 NORTH AMERICA ULTRASOUND IN FAT REDUCTION MARKET, BY REGION, 2019-2033 (USD MILLION)
TABLE 15 NORTH AMERICA ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 16 NORTH AMERICA RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 17 NORTH AMERICA LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 18 NORTH AMERICA MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 19 NORTH AMERICA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 20 NORTH AMERICA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)
TABLE 21 NORTH AMERICA KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 22 NORTH AMERICA PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 23 NORTH AMERICA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 24 NORTH AMERICA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 25 NORTH AMERICA FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)
TABLE 26 NORTH AMERICA FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)
TABLE 27 NORTH AMERICA FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)
TABLE 28 NORTH AMERICA HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 29 NORTH AMERICA HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)
TABLE 30 NORTH AMERICA FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)
TABLE 31 U.S. FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 32 U.S. SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 33 U.S. LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 34 U.S. LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 35 U.S. LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 36 U.S. LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 37 U.S. FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 38 U.S. SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 39 U.S. SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 40 U.S. SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 41 U.S. CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)
TABLE 42 U.S. CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 43 U.S. CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP
TABLE 44 U.S. PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 45 U.S. PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 46 U.S. PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 47 U.S. NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 48 U.S. NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 49 U.S. NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 50 U.S. CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 51 U.S. CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 52 U.S. CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 53 U.S. CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 54 U.S.ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 55 U.S. ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 56 U.S. ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 57 U.S. ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 58 U.S. RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 59 U.S. LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 60 U.S. MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 61 U.S. INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 62 U.S. INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 63 U.S. INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 64 U.S. DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)
TABLE 65 U.S. DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 66 U.S. DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP
TABLE 67 U.S. KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 68 U.S. PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 69 U.S. FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 70 U.S. FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 71 U.S. FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 72 U.S. FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 73 U.S. FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 74 U.S. FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 75 U.S. FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)
TABLE 76 U.S. FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)
TABLE 77 U.S. FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)
TABLE 78 U.S. HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 79 U.S. HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)
TABLE 80 U.S. FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)
TABLE 81 CANADA FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 82 CANADA SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 83 CANADA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 84 CANADA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 85 CANADA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 86 CANADA LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 87 CANADA FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 88 CANADA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 89 CANADA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 90 CANADA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 91 CANADA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)
TABLE 92 CANADA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 93 CANADA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP
TABLE 94 CANADA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 95 CANADA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 96 CANADA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 97 CANADA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 98 CANADA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 99 CANADA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 100 CANADA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 101 CANADA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 102 CANADA CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 103 CANADA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 104 CANADAULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 105 CANADA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 106 CANADA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 107 CANADA ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 108 CANADA RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 109 CANADA LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 110 CANADA MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 111 CANADA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 112 CANADA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 113 CANADA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 114 CANADA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)
TABLE 115 CANADA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 116 CANADA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP
TABLE 117 CANADA KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 118 CANADA PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 119 CANADA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 120 CANADA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 121 CANADA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 122 CANADA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 123 CANADA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 124 CANADA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 125 CANADA FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)
TABLE 126 CANADA FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)
TABLE 127 CANADA FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)
TABLE 128 CANADA HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 129 CANADA HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)
TABLE 130 CANADA FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)
TABLE 131 MEXICO FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 132 MEXICO SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 133 MEXICO LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 134 MEXICO LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 135 MEXICO LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 136 MEXICO LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 137 MEXICO FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 138 MEXICO SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 139 MEXICO SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 140 MEXICO SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 141 MEXICO CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)
TABLE 142 MEXICO CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 143 MEXICO CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP
TABLE 144 MEXICO PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 145 MEXICO PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 146 MEXICO PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 147 MEXICO NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 148 MEXICO NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 149 MEXICO NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 150 MEXICO CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 151 MEXICO CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 152 MEXICO CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 153 MEXICO CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 154 MEXICOULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 155 MEXICO ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 156 MEXICO ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 157 MEXICO ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 158 MEXICO RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 159 MEXICO LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 160 MEXICO MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 161 MEXICO INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 162 MEXICO INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 163 MEXICO INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 164 MEXICO DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)
TABLE 165 MEXICO DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 166 MEXICO DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP
TABLE 167 MEXICO KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 168 MEXICO PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 169 MEXICO FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 170 MEXICO FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 171 MEXICO FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 172 MEXICO FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 173 MEXICO FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 174 MEXICO FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 175 MEXICO FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)
TABLE 176 MEXICO FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)
TABLE 177 MEXICO FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)
TABLE 178 MEXICO HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 179 MEXICO HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)
TABLE 180 MEXICO FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)
TABLE 181 COSTA RICA FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 182 COSTA RICA SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 183 COSTA RICA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 184 COSTA RICA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 185 COSTA RICA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 186 COSTA RICA LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 187 COSTA RICA FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 188 COSTA RICA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 189 COSTA RICA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 190 COSTA RICA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 191 COSTA RICA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)
TABLE 192 COSTA RICA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 193 COSTA RICA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP
TABLE 194 COSTA RICA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 195 COSTA RICA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 196 COSTA RICA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 197 COSTA RICA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 198 COSTA RICA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 199 COSTA RICA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 200 COSTA RICA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 201 COSTA RICA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 202 COSTA RICA CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 203 COSTA RICA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 204 COSTA RICAULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 205 COSTA RICA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 206 COSTA RICA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 207 COSTA RICA ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 208 COSTA RICA RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 209 COSTA RICA LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 210 COSTA RICA MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 211 COSTA RICA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 212 COSTA RICA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 213 COSTA RICA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 214 COSTA RICA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)
TABLE 215 COSTA RICA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 216 COSTA RICA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP
TABLE 217 COSTA RICA KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 218 COSTA RICA PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 219 COSTA RICA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 220 COSTA RICA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 221 COSTA RICA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 222 COSTA RICA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 223 COSTA RICA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 224 COSTA RICA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 225 COSTA RICA FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)
TABLE 226 COSTA RICA FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)
TABLE 227 COSTA RICA FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)
TABLE 228 COSTA RICA HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 229 COSTA RICA HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)
TABLE 230 COSTA RICA FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)
TABLE 231 DOMINICAN REPUBLIC FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 232 DOMINICAN REPUBLIC SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 233 DOMINICAN REPUBLIC LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 234 DOMINICAN REPUBLIC LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 235 DOMINICAN REPUBLIC LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 236 DOMINICAN REPUBLIC LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 237 DOMINICAN REPUBLIC FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 238 DOMINICAN REPUBLIC SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 239 DOMINICAN REPUBLIC SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 240 DOMINICAN REPUBLIC SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 241 DOMINICAN REPUBLIC CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)
TABLE 242 DOMINICAN REPUBLIC CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 243 DOMINICAN REPUBLIC CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP
TABLE 244 DOMINICAN REPUBLIC PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 245 DOMINICAN REPUBLIC PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 246 DOMINICAN REPUBLIC PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 247 DOMINICAN REPUBLIC NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 248 DOMINICAN REPUBLIC NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 249 DOMINICAN REPUBLIC NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 250 DOMINICAN REPUBLIC CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 251 DOMINICAN REPUBLIC CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 252 DOMINICAN REPUBLIC CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 253 DOMINICAN REPUBLIC CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 254 DOMINICAN REPUBLICULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 255 DOMINICAN REPUBLIC ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 256 DOMINICAN REPUBLIC ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 257 DOMINICAN REPUBLIC ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 258 DOMINICAN REPUBLIC RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 259 DOMINICAN REPUBLIC LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 260 DOMINICAN REPUBLIC MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 261 DOMINICAN REPUBLIC INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 262 DOMINICAN REPUBLIC INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 263 DOMINICAN REPUBLIC INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 264 DOMINICAN REPUBLIC DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)
TABLE 265 DOMINICAN REPUBLIC DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 266 DOMINICAN REPUBLIC DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP
TABLE 267 DOMINICAN REPUBLIC KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 268 DOMINICAN REPUBLIC PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 269 DOMINICAN REPUBLIC FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 270 DOMINICAN REPUBLIC FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 271 DOMINICAN REPUBLIC FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 272 DOMINICAN REPUBLIC FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 273 DOMINICAN REPUBLIC FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 274 DOMINICAN REPUBLIC FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 275 DOMINICAN REPUBLIC FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)
TABLE 276 DOMINICAN REPUBLIC FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)
TABLE 277 DOMINICAN REPUBLIC FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)
TABLE 278 DOMINICAN REPUBLIC HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 279 DOMINICAN REPUBLIC HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)
TABLE 280 DOMINICAN REPUBLIC FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)
TABLE 281 PANAMA FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 282 PANAMA SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 283 PANAMA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 284 PANAMA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 285 PANAMA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 286 PANAMA LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 287 PANAMA FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 288 PANAMA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 289 PANAMA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 290 PANAMA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 291 PANAMA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)
TABLE 292 PANAMA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 293 PANAMA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP
TABLE 294 PANAMA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 295 PANAMA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 296 PANAMA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 297 PANAMA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 298 PANAMA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 299 PANAMA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 300 PANAMA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 301 PANAMA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 302 PANAMA CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 303 PANAMA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 304 PANAMAULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 305 PANAMA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 306 PANAMA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 307 PANAMA ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 308 PANAMA RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 309 PANAMA LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 310 PANAMA MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 311 PANAMA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 312 PANAMA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 313 PANAMA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 314 PANAMA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)
TABLE 315 PANAMA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 316 PANAMA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP
TABLE 317 PANAMA KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 318 PANAMA PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 319 PANAMA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 320 PANAMA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 321 PANAMA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 322 PANAMA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 323 PANAMA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 324 PANAMA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 325 PANAMA FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)
TABLE 326 PANAMA FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)
TABLE 327 PANAMA FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)
TABLE 328 PANAMA HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 329 PANAMA HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)
TABLE 330 PANAMA FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)
TABLE 331 EL SALVADOR FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 332 EL SALVADOR SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 333 EL SALVADOR LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 334 EL SALVADOR LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 335 EL SALVADOR LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 336 EL SALVADOR LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 337 EL SALVADOR FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 338 EL SALVADOR SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 339 EL SALVADOR SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 340 EL SALVADOR SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 341 EL SALVADOR CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)
TABLE 342 EL SALVADOR CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 343 EL SALVADOR CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP
TABLE 344 EL SALVADOR PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 345 EL SALVADOR PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 346 EL SALVADOR PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 347 EL SALVADOR NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 348 EL SALVADOR NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 349 EL SALVADOR NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 350 EL SALVADOR CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 351 EL SALVADOR CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 352 EL SALVADOR CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 353 EL SALVADOR CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 354 EL SALVADORULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 355 EL SALVADOR ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 356 EL SALVADOR ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 357 EL SALVADOR ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 358 EL SALVADOR RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 359 EL SALVADOR LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 360 EL SALVADOR MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 361 EL SALVADOR INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 362 EL SALVADOR INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 363 EL SALVADOR INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 364 EL SALVADOR DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)
TABLE 365 EL SALVADOR DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 366 EL SALVADOR DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP
TABLE 367 EL SALVADOR KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 368 EL SALVADOR PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 369 EL SALVADOR FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 370 EL SALVADOR FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 371 EL SALVADOR FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 372 EL SALVADOR FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 373 EL SALVADOR FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 374 EL SALVADOR FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 375 EL SALVADOR FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)
TABLE 376 EL SALVADOR FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)
TABLE 377 EL SALVADOR FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)
TABLE 378 EL SALVADOR HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 379 EL SALVADOR HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)
TABLE 380 EL SALVADOR FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)
TABLE 381 GUATEMALA FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 382 GUATEMALA SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 383 GUATEMALA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 384 GUATEMALA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 385 GUATEMALA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 386 GUATEMALA LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 387 GUATEMALA FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 388 GUATEMALA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 389 GUATEMALA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 390 GUATEMALA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 391 GUATEMALA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)
TABLE 392 GUATEMALA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 393 GUATEMALA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP
TABLE 394 GUATEMALA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 395 GUATEMALA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 396 GUATEMALA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 397 GUATEMALA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 398 GUATEMALA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 399 GUATEMALA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 400 GUATEMALA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 401 GUATEMALA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 402 GUATEMALA CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 403 GUATEMALA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 404 GUATEMALAULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 405 GUATEMALA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 406 GUATEMALA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 407 GUATEMALA ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 408 GUATEMALA RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 409 GUATEMALA LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 410 GUATEMALA MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 411 GUATEMALA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 412 GUATEMALA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 413 GUATEMALA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 414 GUATEMALA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)
TABLE 415 GUATEMALA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 416 GUATEMALA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP
TABLE 417 GUATEMALA KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 418 GUATEMALA PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 419 GUATEMALA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 420 GUATEMALA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 421 GUATEMALA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 422 GUATEMALA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 423 GUATEMALA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 424 GUATEMALA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 425 GUATEMALA FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)
TABLE 426 GUATEMALA FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)
TABLE 427 GUATEMALA FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)
TABLE 428 GUATEMALA HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 429 GUATEMALA HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)
TABLE 430 GUATEMALA FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)
TABLE 431 HONDURAS FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 432 HONDURAS SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 433 HONDURAS LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 434 HONDURAS LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 435 HONDURAS LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 436 HONDURAS LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 437 HONDURAS FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 438 HONDURAS SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 439 HONDURAS SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 440 HONDURAS SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 441 HONDURAS CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)
TABLE 442 HONDURAS CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 443 HONDURAS CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP
TABLE 444 HONDURAS PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 445 HONDURAS PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 446 HONDURAS PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 447 HONDURAS NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 448 HONDURAS NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 449 HONDURAS NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 450 HONDURAS CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 451 HONDURAS CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 452 HONDURAS CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 453 HONDURAS CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 454 HONDURASULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 455 HONDURAS ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 456 HONDURAS ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 457 HONDURAS ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 458 HONDURAS RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 459 HONDURAS LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 460 HONDURAS MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 461 HONDURAS INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 462 HONDURAS INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 463 HONDURAS INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 464 HONDURAS DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)
TABLE 465 HONDURAS DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 466 HONDURAS DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP
TABLE 467 HONDURAS KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 468 HONDURAS PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 469 HONDURAS FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 470 HONDURAS FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 471 HONDURAS FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 472 HONDURAS FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 473 HONDURAS FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 474 HONDURAS FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 475 HONDURAS FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)
TABLE 476 HONDURAS FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)
TABLE 477 HONDURAS FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)
TABLE 478 HONDURAS HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 479 HONDURAS HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)
TABLE 480 HONDURAS FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)
TABLE 481 NICARAGUA FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 482 NICARAGUA SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 483 NICARAGUA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 484 NICARAGUA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 485 NICARAGUA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 486 NICARAGUA LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 487 NICARAGUA FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 488 NICARAGUA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 489 NICARAGUA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 490 NICARAGUA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 491 NICARAGUA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)
TABLE 492 NICARAGUA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 493 NICARAGUA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP
TABLE 494 NICARAGUA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 495 NICARAGUA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 496 NICARAGUA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 497 NICARAGUA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 498 NICARAGUA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 499 NICARAGUA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 500 NICARAGUA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 501 NICARAGUA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 502 NICARAGUA CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 503 NICARAGUA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 504 NICARAGUAULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 505 NICARAGUA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 506 NICARAGUA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 507 NICARAGUA ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 508 NICARAGUA RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 509 NICARAGUA LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 510 NICARAGUA MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 511 NICARAGUA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 512 NICARAGUA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 513 NICARAGUA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 514 NICARAGUA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)
TABLE 515 NICARAGUA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 516 NICARAGUA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP
TABLE 517 NICARAGUA KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 518 NICARAGUA PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 519 NICARAGUA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 520 NICARAGUA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 521 NICARAGUA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 522 NICARAGUA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 523 NICARAGUA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 524 NICARAGUA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 525 NICARAGUA FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)
TABLE 526 NICARAGUA FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)
TABLE 527 NICARAGUA FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)
TABLE 528 NICARAGUA HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 529 NICARAGUA HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)
TABLE 530 NICARAGUA FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)
图片列表
FIGURE 1 NORTH AMERICA FAT REDUCTION MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA FAT REDUCTION MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA FAT REDUCTION MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA FAT REDUCTION MARKET: COUNTRY VS. REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA FAT REDUCTION MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA FAT REDUCTION MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA FAT REDUCTION MARKET: MULTIVARIATE MODELLING
FIGURE 8 NORTH AMERICA FAT REDUCTION MARKET: DBMR MARKET POSITION GRID
FIGURE 9 NORTH AMERICA FAT REDUCTION MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA FAT REDUCTION MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 11 NORTH AMERICA FAT REDUCTION MARKET: SEGMENTATION
FIGURE 12 INCREASING DEMAND FOR NON-INVASIVE AND MINIMALLY INVASIVE AESTHETIC PROCEDURES IS EXPECTED TO DRIVE THE NORTH AMERICA FAT REDUCTION MARKET GROWTH IN THE FORECAST PERIOD FROM 2023 TO 2033
FIGURE 13 THE SURGICAL FAT REDUCTION SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA FAT REDUCTION MARKET IN 2023 & 2033
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA FAT REDUCTION MARKET
FIGURE 15 NORTH AMERICA FAT REDUCTION MARKET: BY TYPE, 2022
FIGURE 16 NORTH AMERICA FAT REDUCTION MARKET: BY TYPE, 2023-2033 (USD MILLION)
FIGURE 17 NORTH AMERICA FAT REDUCTION MARKET: BY TYPE, CAGR (2023-2033)
FIGURE 18 NORTH AMERICA FAT REDUCTION MARKET: BY TYPE, LIFELINE CURVE
FIGURE 19 NORTH AMERICA FAT REDUCTION MARKET: BY APPLICATION, 2022
FIGURE 20 NORTH AMERICA FAT REDUCTION MARKET: BY APPLICATION, 2023-2033 (USD MILLION)
FIGURE 21 NORTH AMERICA FAT REDUCTION MARKET: BY APPLICATION, CAGR (2023-2033)
FIGURE 22 NORTH AMERICA FAT REDUCTION MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 23 NORTH AMERICA FAT REDUCTION MARKET: BY GENDER, 2022
FIGURE 24 NORTH AMERICA FAT REDUCTION MARKET: BY GENDER, 2023-2033 (USD MILLION)
FIGURE 25 NORTH AMERICA FAT REDUCTION MARKET: BY GENDER, CAGR (2023-2033)
FIGURE 26 NORTH AMERICA FAT REDUCTION MARKET: BY GENDER, LIFELINE CURVE
FIGURE 27 NORTH AMERICA FAT REDUCTION MARKET: BY AGE GROUP, 2022
FIGURE 28 NORTH AMERICA FAT REDUCTION MARKET: BY AGE GROUP, 2023-2033 (USD MILLION)
FIGURE 29 NORTH AMERICA FAT REDUCTION MARKET: BY AGE GROUP, CAGR (2023-2033)
FIGURE 30 NORTH AMERICA FAT REDUCTION MARKET: BY AGE GROUP, LIFELINE CURVE
FIGURE 31 NORTH AMERICA FAT REDUCTION MARKET: BY END USER, 2022
FIGURE 32 NORTH AMERICA FAT REDUCTION MARKET: BY END USER, 2023-2033 (USD MILLION)
FIGURE 33 NORTH AMERICA FAT REDUCTION MARKET: BY END USER, CAGR (2023-2033)
FIGURE 34 NORTH AMERICA FAT REDUCTION MARKET: BY END USER, LIFELINE CURVE
FIGURE 35 NORTH AMERICA FAT REDUCTION MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 36 NORTH AMERICA FAT REDUCTION MARKET: BY DISTRIBUTION CHANNEL, 2023-2033 (USD MILLION)
FIGURE 37 NORTH AMERICA FAT REDUCTION MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2033)
FIGURE 38 NORTH AMERICA FAT REDUCTION MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 39 NORTH AMERICA FAT REDUCTION MARKET: SNAPSHOT (2022)
FIGURE 40 NORTH AMERICA FAT REDUCTION MARKET: BY COUNTRY (2022)
FIGURE 41 NORTH AMERICA FAT REDUCTION MARKET: BY COUNTRY (2023 & 2033)
FIGURE 42 NORTH AMERICA FAT REDUCTION MARKET: BY COUNTRY (2022 & 2033)
FIGURE 43 NORTH AMERICA FAT REDUCTION MARKET: BY TYPE (2023-2033)
FIGURE 44 NORTH AMERICA FAT REDUCTION MARKET: COMPANY SHARE 2022 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.